chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This case was reported by a consumer and described the occurrence of general malaise in a female patient who received SHINGRIX. Concomitant products included SHINGRIX. On 24th April 2018, the patient received the 2nd dose of SHINGRIX. On an unknown date, less than a month after receiving SHINGRIX, the patient experienced general malaise, chills, tiredness, appetite lost, sleepiness, energy decreased, pain in arm, injection site erythema and influenza-like symptoms. On an unknown date, the outcome of the general malaise, chills, tiredness, appetite lost, sleepiness, energy decreased, pain in arm, injection site erythema and influenza-like symptoms were recovered/resolved. It was unknown if the reporter considered the general malaise, chills, tiredness, appetite lost, sleepiness, energy decreased, pain in arm, injection site erythema and influenza-like symptoms to be related to SHINGRIX. Additional details were provided as follows: This case was reported by the patient's husband. The age at vaccination was not reported. On 17th February 2018, the patient received 1st dose of SHINGRIX concomitantly and she had no issues at all. The patient had a reaction that gave her general malaise included chills, tiredness, loss of appetite, sleepiness, low energy, her arm hurt a lot with erythema around injection site. The patient described that reaction as flu like symptoms although without an elevated body temperature and the symptoms lasted about 24 hours. The reporter was asking if you need additional information, please contact him.
First was a headache for about a month and one or two a week ever since. I got a rash on top of my left foot/ ankle that resembeled shingles about a week after first shot. The same thing hapened after my second shot  on my right foot and ankle a week after my second shot. Have had heart palpitations and occasional rapid heartbeat  since a week after second covid shot
NO adverse reactions.  Patient received the Pfizer monovalent vaccine noted above instead of receiving the Pfizer bivalent vaccine booster.  Pt notified of vaccine error, denies any side effects/adverse effects.
Information has been received concerning a 7 year old male who on 27-JUN-2007 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). On 06-AUG-2007, the patient developed a generalized itchy rash. On 09-AUG-2007, the patient was seen in the office. At that time there were about 30 papules and a few pustules concentrated on the lower trunk and upper legs. Subsequently, the patient recovered after about 10 days on 16-AUG-2007. No further information was provided. There was no product quality complaint involved. Additional information is not expected. The patient's brother also had an adverse event after vaccination with varicella virus vaccine live (Oka/Merck) (WAES#0708USA04378).
-Within a few days of my 1/7/22 1st booster, my Myasthenia Gravis symptoms became worse than they'd ever been.  -Myasthenia Symptoms: difficulty breathing due to weak respiratory muscles, choking on food because of muscle weakness, difficulty walking, difficulty using arms/hands/legs due to muscle weakness. -Over the course of 1/7/22 to 1/18/22 I was having multiple events a day where I kept thinking "oh I should go to the hospital", but was unsure what they would do to help me. I'm already on Mestinon, which is intended to help me with muscle weakness from Myasthenia, but the new/really scary symptoms kept getting worse. -On 1/18/22 I waited 21 hrs in the ER; was admitted from 1/19/22-1/21/22 and given one IVIG infusion to counteract my issues. The IVIG has helped somewhat but I'm still severely struggling with aforementioned symptoms.  -***Please note that the "start" of daily Myasthenia symptoms began within 7 days of my Moderna shot #2 in April 2021. *** In summary, I believe that the vaccines have very very much intensified some dormant autoimmune issues that may have been around.
1/11 evening after 2nd injection nagging headache frontal, fatigue X 2 days took tylenol
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. The patients' medical history was not reported. On an unknown dates, the patients were vaccinated with improperly stored doses of PROQUAD (Merck) lot # L023112, expiration date reported as 24-DEC-2016, lot # K011311, expiration date reported as 14-FEB-2016, lot # L009209, expiration date reported as 17-SEP-2016. No adverse effect was reported. This is one of several reports from the same report. Additional information has been requested.
Pt was given vaccine Friday 3-11-16 and over weekend had fever (resolved), wouldn't walk (resolved), red streak (resolved) and leg was twice the size of other leg.
Body ache from top of head to ankles, chills, could not get warm, nausea, weakness
edema / L>R lower extremity edema / worsening edema and right LE is worse; Unable to walk; hand pain/ unable to walk because of pain; This case was reported by a nurse via call center representative and described the occurrence of edema of lower extremities in a 17-year-old female patient who received Men B NVS (Bexsero) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   On an unknown date, the patient received Bexsero and Bexsero Pre-Filled Syringe Device. On an unknown date, several days after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced edema of lower extremities, unable to walk and pain in extremity. On an unknown date, the outcome of the edema of lower extremities was not recovered/not resolved and the outcome of the unable to walk and pain in extremity were unknown.   It was unknown if the reporter considered the edema of lower extremities, unable to walk and pain in extremity to be related to Bexsero and Bexsero Pre-Filled Syringe Device.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The age at vaccination was not reported. The reporter asked if edema had been reported as an adverse reaction after bexsero.  Few days after taking Bexsero, the patient had lower extremity edema (left more than right).  The patient had negative ultrasound for blood clot and negative xray for fracture. On 8th February 2021, the patient returned with yet worsening edema and right lower extremity was worse as well. The patient was unable to walk because of pain and also had some hand pain. The reporter did not consent to follow-up.  The reporter disconnected the chat abruptly and therefore any additional details could not be gathered.
Vx reconstituted with sterile water; Vx reconstituted with sterile water; This case was reported by a nurse via call center representative and described the occurrence of wrong solution used in drug reconstitution in a 53-year-old male patient who received Herpes zoster (Shingrix) (batch number PG35Z, expiry date unknown) for prophylaxis.   On 5th October 2021, the patient received Shingrix. On 5th October 2021, unknown after receiving Shingrix, the patient experienced wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. On an unknown date, the outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were unknown.  Additional details were provided as follows: The nurse reported that the patient received the Shingrix after it was reconstituted with sterile water instead of the GlaxoSmithKline supplied adjuvant, which led to wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. It was unknown whether or not it was the first or second dose. The reporter consented to follow up. This case has been linked with the case US2021209469 reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021209469:Same reporter. Patient 2 of 2.
Hospitalization occurred but this was due to GI bleed which could be attributed to her GI cancer.
Patient given Fluarix instead of Tdap vaccine.  Patient had received Fluvirin on 9/19/14.  Dr. notified of event.  No treatment necessary.  Patient called and informed of above.
Fever x 7 days, rash x 5 days - resolved. Decreased appetite and weight loss of 6 oz - worsening. Decreased attention span. Increased sleep daytime - worsening.
Pain went directly to shoulder joint or rotor cuff area, as been 7 weeks, worse now
Sharp chest pain and left shoulder blade/back pain with difficulty taking deep breaths. Did not report initially because it went away after a few days, but after reading the studies wondering if she had the myocarditis/pericarditis side effects.
I gave the vaccine to the patient after the patient dropped off a prescription from the doctor's office. The patient was totally fine after and before I gave the vaccine. But when he was trying to get up the chair and leave the immunization room he felt so dizzy but he didn't faint. He was able to talk, breath normal. I offered him water and juice. I checked his blood pressure three times until reached 97/64. Then he left the store.
PUBLIC HEALTH NURSE QUESTIONED MOM ON HISTORY SEIZURES.  MOM SAID NONE.  IMMEDIATELY AFTER VACCINE ADMINISTRATION, CLIENT HAD MILD SEIZURE LIKE ACTIVITY LASTING 45 SECONDS.  OBSERVED FOR 30 MINUTES.  REFERRAL TO MD FOR EVALUATION.  BP 110/60. WAS AT SCHOOL ON 9/23/08 APPT PENDING WITH NEUROLOGIST EVAL., SINCE 2ND SEIZURE LIKE ACTIVITY.  FIRST OCCURRED IN CHILDHOOLD AFTER BUMP TO HEAD.  IN SCHOOL SINCE 9/23 WITH NO PROBLEMS NOTED.
Headache. Dizziness, Nausea,  body ache, tired, sore left arm
High white blood cells; Pressure on eyes; A spontaneous report was received from a consumer concerning a 74-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events high white blood cells/white blood cell count increased, pressure on eyes/ocular discomfort.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On unknown date, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: unknown) via unknown route for prophylaxis of COVID-19 infection.  On an unknown date, four weeks after receiving the vaccine dose the patient experienced the event high white blood cells. The patient was hospitalized and was still in the hospital with 3 weeks because of high white blood cells. On unknown date the patient experienced the event pressure on eyes. The patient also had tested negative for COVID on unknown date.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event high white blood cells, pressure on eyes was unknown.; Reporter's Comments: This case concerns a 74-year-old female hospitalized with serious unexpected events of white blood cell count increased and ocular discomfort. SARS-CoV-2 test negative. Event onset occurred 4 weeks after the first dose of mRNA-1273. Treatment not reported. Event outcome resolved. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Guillain Barre upgraded to reoccuring Guillain Barre (aka CIDP)  Diabetes Type I
Shortly after receiving vaccine, became SOB, with chest tightness; & hives covering body; transferred by ambulance to ER; Txed with BENADRYL & SOLU-MEDROL; has recovered with minimal itching.
Started feeling tired and wiped out and went to bed around 8 pm around midnight woke up to extremely high fever  with significant chills, shaking and muscles in head and neck locked in middle of the night extreme difficulty swallowing pills.  Aching pain in all joints.  Fever did respond to tylenol and gatorade after several hours.  Still significant pain in injection site post 24 hours even with massage therapy and hot shower.
Vaccine given to patient less than 18ys of age. Per pcp requested VAERS to be entered . Patient and mother  spent time during observation with provider for
Symptoms: red raised and scaly rash on neck, face, eyelids, breasts + swollen lips + swelling of eyelids and eye sockets + dark red circles in eye sockets + severe fatigue  Treatment: Desonide cream 2/8-2/11, Prednisone 2/14-2/16, Atrax 2/16-2/18  Outcome: active period of incident lasted until 2/19/21, as of 2/20/21 rash and red circles around eyes fading but slight eyelid welling and severe skin dryness and flaking remains around eye sockets (aloe gel directly from plant is the only treatment that seems to help)
On 2/23/2021 @ 1:00 A.M.;- exactly one week after receiving my first dose of the Moderna CoVid 19 Vaccine on 2/16/21; I developed hives and itching on my left arm at the vaccination site. I awoke @ 10 A.M. on 2/23/2021 with  itching ,  hives, redness and soreness  in  the same area. As of this writing, circa 3:45 P.M., the redness and itching persists. This is the only adverse reaction I have had thus far from the vaccine.
This spontaneous report was received from a nurse referring to unspecified patients of unknown age and gender. The patients' medical histories and concurrent conditions were not reported. On unspecified dates since 24-OCT-2015, the patients were vaccinated with doses of PNEUMOVAX 23 (Lot# L029113; expiration date 27-MAR-2017) (dose and route of administration were not reported), which were exposed to temperatures outside of the recommended range. Concomitant therapies were not reported. No adverse experiences have been reported. There was no product quality complaint (PQC) involved. This is one of several reports from the same source. Additional information has been requested.
I was pretty fatigue and tired and had chills the night of the day of vaccination. The next mornings, Saturday and Sunday, I had some chest pressure. It happened again on Monday morning so I went to work but I couldn't ignore it anymore so I told my boss I was going to the emergency room. I went to a local medical center and they ran blood work and discovered Troponin in my blood levels. They also did EKG and Chest X-ray to check my lungs and respiratory system. I was informed to take baby Aspirin until cleared by the Cardiologist on a follow-up appointment to stop taking it.
HAD PAIN AND TINGLING ON LEFT HAND AND FINGERS FOR SEVEREAL DAYS FOLLOWING VACCINATION
STOMACH PAINS; This spontaneous report received from a patient concerned a 29-year-old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, expiry date: unknown) dose was not reported, administered on 12-MAY-2021 for prophylactic vaccination. The batch number was not reported and has been requested.  No concomitant medications were reported. On 11-MAY-2021, Laboratory data included: COVID-19 virus test (NR: not provided) Negative. On 13-MAY-2021, the subject experienced stomach pains. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from stomach pains. This report was non-serious.
He had his COVID vaccine 6 days prior at Walgreens and since that time he has developed periorbital edema, rash and is concerned he has had an "allergic reaction" to the vaccination. He has noted rash on his arms and face.
Loss of approximately 90% of taste.  Always. All foods and beverages.  Everything has a slight metallic taste.
infection at injection site. was prescribed Bactrim DS 800-160mg and cephalexin 250mg.
9APR90 vaccinee rec'd Engerix B & began to feel dizzy, weak, unwell & had an acute myocardial infarction; The vaccine caused severe hypotension, coronary artery spasm & superimposed coronary thrombosis;
on 11/23/22 and 1/24/23 patient received 2 unindicated bivalent boosters.  When he came in to request another booster we noticed he had already received 2 additional boosters on the dates listed. We are reporting the 2 additional boosters received that were not indicated on 11/23/22 and 1/24/23. The patient did not report any side effects or issues after receiving the additional boosters.
Patient reports a redness and inflammation around the injection site, no fever or any other signs of infection at the moment of the report.  Patient was advised to contact her PCP ASAP.
This spontaneous report was received from the patient's mother, concerning a 17 year old female patient. The patient did not have pertinent medical history or concomitant medications. She is allergic to amoxicillin since she was a baby; it gave her hives and itching. In April, June and November 2012, the patient was vaccinated with GARDASIL, as 3 series injections for prevention of Human Papillomavirus (HPV), the route of administration was reported as injection (lot #, expiration date, strength or anatomical location were not provided). It was stated that after each injection with GARDASIL, the patient developed body aches, fatigue and body weakness that resolved in about a week. On 19-JUN-2018, the patient received an injection of GARDASIL 9 (lot #, expiration date, strength, or anatomical location were not provided) for the same indication, due to an administrative error. After vaccination the patient experienced body aches, muscle weakness and fatigue. The patient did not seek medical attention; so no treatment was given for any of the above reported events and no laboratory diagnostics studies were performed. At the reporting time, the patient was experiencing body aches, muscle weakness and fatigue. The causal relationship between body aches, fatigue, body weakness and muscle weakness with GARDASIL was not provided. The causal relationship between body aches, body weakness and fatigue with onset date in 2012 and GARDASIL 9 was not related, and for the all the above mentioned events from 19-JUN-2018 was not provided.
Chills, fever, muscle ache, headache, weakness ? Tylenol 1000 mg alternating with ibuprofen 400 mg q 4 hrs, tachycardia hr 130-150 resting with chest palpitations. No SoB or chest pain noted, no adderall taken that day. Elevated hr noted second day with orthostatic tachycardia exacerbated standing. Pulse rate regular, BP 129/93. Tachycardia lasting from second day post vaccination until fourth day for total about 48+ hrs in tachycardia. No treatment was pursued at that time.
Hives; Hands are swollen; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of URTICARIA (Hives) and PERIPHERAL SWELLING (Hands are swollen) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, the patient experienced URTICARIA (Hives) and PERIPHERAL SWELLING (Hands are swollen). At the time of the report, URTICARIA (Hives) and PERIPHERAL SWELLING (Hands are swollen) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient was not on concomitant medications. The patient went to doctor and doctor said that  events were not related to vaccine and said she had a reaction to something else. Treatment medications included unspecified medication for allergies.  Action taken with mRNA-1273 in response to the event was unknown   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Additional information received captured reporter contact details, events outcome and causality.
sore & stiff & then evening of 14JUL93 starting swelling @ site of inject then woke up 15JUL93 w/elevated t99.8 & swelling of armpits; redness & swelling @ inject site & under arm;  c/o h/a since Tues evening 13JUL93;
Information has been received from a 19 year old female with no pertinent medical history or drug reaction/allergies, who on 14-AUG-2008 was vaccinated with the first dose of GARDASIL.  There was no concomitant medication.  The patient found that she was pregnant 2 weeks ago on approximately 31-JUL-2008.  As of 04-SEP-2008 the patient was 7 weeks gestation.  The patient's LMP was 14-JUL-2008 and EDD 21-APR-2009.  She had three pregnancy tests.  The patient saw the physician in the office.  No adverse event reported.  Additional information has been requested.
10 days out from vaccine and still have major dizziness, lightheaded, visual changes, major head aches, and if headaches get bad enough then ringing in ears.
Woke up this morning and arm was sore, was at work started to develop a headache.  Went home vomited and has been "weak" all day.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. Pharmacist mentioned a shipment of ZOSTAVAX and VARIVAX (Merck) were received with a 4 days shipping time period were given to patients (unknown date). Pharmacist stated the shipment was received and the ice packs were still frozen and the ZOSTAVAX and VARIVAX (Merck) were stored in the freezer. There were 9 patients who received ZOSTAVAX. On 06-FEB-2013, one of them was vaccinated with ZOSTAVAX lot # H019040, Expire date:17-JAN-2014 (route and dose not reported). No concomitant Medication were reported. The patient was not experiencing any known symptoms. Patient's outcome was unknown. This is one of several reports received from the same source. Additional information has been requested.
This spontaneous report was received from a physician via a company representative and refers to a currently 36-year-old female patient. The patient's concurrent conditions, medical history and concomitant medications were not reported. On an unknown date, the patient was vaccinated with M-M-R II (lot #, expiration date, dose and frequency and route of administration were not provided) for prophylaxis. On an unknown date post-vaccination, the patient had titers drawn and the result showed low titers, specifically less than 9 (units not provided) for mumps. No clarifying information was provided. At the time of this report, the outcome of the event was unknown. The reporter did not provide the causality between the event and the M-M-R II vaccine.
Red erythema 2cm on (R) thigh (anterior) no rash/redness anywhere else on body tx: apply cool pack to area.
Arthralgia in hands; This is a spontaneous report from a contactable consumer (patient). A 73-year-old female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on an unknown date at single dose for covid-19 immunization. Medical history was reported as none and concomitant medications were not reported. The patient experienced arthralgia in hands on 29Jan2021. The event was treated with Acetaminophen. Therapeutic measures were taken as a result of arthralgia in hands. The outcome of the event was not recovered.  Information on the lot/batch number has been requested.
RASH ON RIGHT ARM, PAINFUL TO LIFT, SORE, TENDERNESS REPORTED 10.08/2009 $ 1400 VIA TELEPHONE.  PATIENT RETURNED TO CLINIC 10/09/2009 @ 0930 RED SPLOTCHES ON ARM FROM SHOULDER TO ELBOW. REPORTS SORENESS FOR THREE DAYS.
Migraine starting 10/10 lasting 6 days, requiringi telemedicine appt and narcotic to arrest. Accompanied by nausea and intermittent chilling of hands and feet which has persisted until present at day 10.  Migraine has recurred today.
Starting about 3 hours after receiving the vaccine, my arm became sore and I was very achy. I had a headache and severe muscle and joint aches. I could feel it "move through my system" and it felt like a severe flu. These symptoms lasted for about 12 hours. I still had the loss of taste and smell from the previous dose.